Modified BRICS sequential regimen in advanced hepatocellular carcinoma patients with BCLC C stage: a real-world study
Patients with advanced hepatocellular carcinoma (HCC) have limited treatment options and poor prognosis. This study evaluates the efficacy and safety of a modified BRICS (Bifidobacterium-based probiotics, Radiotherapy, Immunotherapy, and anti-angiogenic therapy with a Stereotactic approach) sequential regimen in a real...